Skip to main content
. 2019 Mar 8;10:335. doi: 10.3389/fimmu.2019.00335

Figure 2.

Figure 2

Participant flowchart. N, number of participants. *Received doses of 1790GAHB with an O-antigen/protein content of 0·059/1 μg (4 participants), 0·29/5 μg (1 participant), and 2·9/50 μg (2 participants) in the parent study.